Quality control of processed chinese materia medica using zingiberis rhizoma as a case study
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: TRUONG, John (University of Western Sydney, The National Institute of Complementary Medicine, School of Science and Health, Campbelltown, Australia)
- Co-author(s): Razmovski-Naumovski, Valentina (University of Western Sydney, Campbelltown, Australia)
Khoo, Cheang (University of Western Sydney, Campbelltown, Australia)
Chan, Kelvin (University of Western Sydney, Campbelltown, Australia)
The processing of Chinese Materia Medica (CMM) pertains to the physical and/or chemical treatment of crude drugs from natural originsand is performed to enhance therapeutic efficacy or reduce toxicity. Content and chemical constituents can be altered during processing and therefore, chemical markers for the quality control of these.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.